Advertisement

Effect of air removal with extracorporeal balloon inflation on incidence of asymptomatic cerebral embolism during cryoballoon ablation of atrial fibrillation

      Background

      Asymptomatic cerebral embolism (ACE) is sometimes detected after cryoballoon ablation of atrial fibrillation. The removal of air bubbles from the cryoballoon before utilization may reduce the rate of ACE.

      Objective

      This study aims to compare the incidence of ACE between a conventional and a novel balloon massaging method during cryoballoon ablation.

      Methods

      Of 175 consecutive patients undergoing initial cryoballoon ablation of paroxysmal atrial fibrillation, 60 (34.3%) patients underwent novel balloon massaging with extracorporeal balloon inflation in saline water (group N) before the cryoballoon was inserted into the body. The remaining 115 (65.7%) patients underwent conventional balloon massaging in saline water while the balloon remained folded (group C). Of those, 86 propensity score–matched patients were included.

      Results

      The baseline characteristics were similar between the 2 groups. In group N, even after balloon massaging in saline water was carefully performed, multiple air bubbles remained on the balloon surface when the cryoballoon was inflated in all cases. Postprocedural cerebral magnetic resonance imaging detected ACE in 14.0% of all patients. The incidence of ACE was significantly lower in group N than in group C (4.7% vs 23.3%; P = .01). According to multivariable analysis, the novel method was the sole factor associated with the presence of ACE (odds ratio 0.161; 95% confidence interval 0.033–0.736; P = .02).

      Conclusion

      Preliminary removal of air bubbles in heparinized saline water with extracorporeal balloon inflation reduced the incidence of ACE. Since conventional balloon massaging failed to remove air bubbles completely, this novel balloon massaging method should be recommended before cryoballoon utilization.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kuck K.H.
        • Brugada J.
        • Fürnkranz A.
        • Metzner A.
        • Ouyang F.
        • Chun K.R.
        • Elvan A.
        • Arentz T.
        • Bestehorn K.
        • Pocock S.J.
        • Albenque J.P.
        • Tondo C.
        • FIRE AND ICE Investigators
        Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation.
        N Engl J Med. 2016; 374: 2235-2345
        • Luik A.
        • Radzewitz A.
        • Kieser M.
        • et al.
        Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority freeze AF study.
        Circulation. 2015; 132: 1311-1319
        • Schmidt M.
        • Dorwarth U.
        • Andresen D.
        • et al.
        German ablation registry: cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation—one-year outcome data.
        Heart Rhythm. 2016; 13: 836-844
        • Straube F.
        • Dorwarth U.
        • Ammar-Busch S.
        • et al.
        • FREEZE Cohort Investigators
        First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation.
        Europace. 2016; 18: 368-375
        • Schmidt B.
        • Gunawardene M.
        • Krieg D.
        • Bordignon S.
        • Fürnkranz A.
        • Kulikoglu M.
        • Herrmann W.
        • Chun K.R.
        A prospective randomized single-center study on the risk of asymptomatic cerebral lesions comparing irrigated radiofrequency current ablation with the cryoballoon and the laser balloon.
        J Cardiovasc Electrophysiol. 2013; 24: 869-874
      1. Nakamura T, Okishige K, Kanazawa T, Yamashita M, Kawaguchi N, Kato N, Aoyagi H, Yamauchi Y, Sasano T, Hirao K. Incidence of silent cerebral infarctions after catheter ablation of atrial fibrillation utilizing the second-generation cryoballoon. EP Europace, euw191, https://doi.org/10.1093/europace/euw191.

        • Neumann T.
        • Kuniss M.
        • Conradi G.
        • et al.
        MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy.
        Europace. 2011; 13: 37-44
        • Herrera Siklódy C.
        • Deneke T.
        • Hocini M.
        • et al.
        Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study.
        J Am Coll Cardiol. 2011; 58: 681-688
        • Tokuda M.
        • Matsuo S.
        • Isogai R.
        • et al.
        Adenosine testing during cryoballoon ablation and radiofrequency ablation for atrial fibrillation: a propensity score-matched analysis.
        Heart Rhythm. 2016; 13: 2128-2134
        • Sacher F.
        • Monahan K.H.
        • Thomas S.P.
        • et al.
        Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study.
        J Am Coll Cardiol. 2006; 47: 2498-2503
        • Franceschi F.
        • Dubuc M.
        • Guerra P.G.
        • Khairy P.
        Phrenic nerve monitoring with diaphragmatic electromyography during cryoballoon ablation for atrial fibrillation: the first human application.
        Heart Rhythm. 2011; 8: 1068-1071
        • Deneke T.
        • Jais P.
        • Scaglione M.
        • et al.
        Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review.
        J Cardiovasc Electrophysiol. 2015; 26: 455-463
        • Haines D.E.
        • Stewart M.T.
        • Barka N.D.
        • Kirchhof N.
        • Lentz L.R.
        • Reinking N.M.
        • Urban J.F.
        • Halimi F.
        • Deneke T.
        • Kanal E.
        Microembolism and catheter ablation. II: Effects of cerebral microemboli injection in a canine model.
        Circ Arrhythm Electrophysiol. 2013; 6: 23-30
        • Ichiki H.
        • Oketani N.
        • Ishida S.
        • Iriki Y.
        • Okui H.
        • Maenosono R.
        • Namino F.
        • Ninomiya Y.
        • Miyata M.
        • Hamasaki S.
        • Tei C.
        The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
        Pacing Clin Electrophysiol. 2013; 36: 1328-1335
        • Ren J.F.
        • Marchlinski F.E.
        • Callans D.J.
        • Gerstenfeld E.P.
        • Dixit S.
        • Lin D.
        • Nayak H.M.
        • Hsia H.H.
        Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast.
        J Cardiovasc Electrophysiol. 2005; 16: 474-477
        • von Bary C.
        • Deneke T.
        • Arentz T.
        • et al.
        Online measurement of microembolic signal burden by transcranial Doppler during catheter ablation for atrial fibrillation—results of a multicenter trial.
        Front Neurol. 2017; 8: 131